Exact Sciences CorporationEXASNASDAQ

103.72-103.95

52-Week Range39-104

38.81Current 103.92104.00

Want to monitor EXAS?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Gross Margin

Operating Margin

Revenue Growth

exact sciences is a molecular diagnostics company focused on colorectal cancer.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Kevin Conroy

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

Why is Planet Labs' stock soaring?

Airline and hospitality stocks lift FTSE 100 as oil price retreats

Best Income Stocks to Buy for March 20th

NAVN Investors Have Opportunity to Lead Navan, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Stock Market Today: Oil Steadies as Israel Signals Restraint

ENPH Investors Have Opportunity to Lead Enphase Energy, Inc. Securities Fraud Lawsuit with the Schall Law Firm

SS&C GlobeOp Forward Redemption Indicator

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm

Atlantic Lithium cheers "watershed moment" as Ewoyaa lithium project's mining lease is ratified

Is Apple Stock Your Ticket to Becoming a Millionaire?

S&P Global: I Believe Artificial Intelligence Is A Blessing Rather Than A Curse

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm

Canadian Apartment Properties: A Record Discount To NAV; Buy

Arrow Exploration looks forward to a continuation successful, low risk drilling campaign

Scholastic Has A New Lease On Life (Rating Upgrade)

Deutsche Lufthansa AG: Mr Carsten Spohr, Acquisition

PSFE Investors Have Opportunity to Lead Paysafe Limited Securities Fraud Lawsuit with the Schall Law Firm

4 Dividend Stocks to Hold for the Next 10 Years

SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

What Are the Best AI Stocks to Buy While Big Tech Is Spending $690 Billion on Infrastructure?

About